Ọgwụ "Teveten." ntụziaka

Teveten bụ a antihypertensive gị n'ụlọnga, ihe na-eti ọkpọ nke angiotensin II anabata. The ọgwụ dị na mbadamba ụdị. Mbadamba nkume nke 400 mg na-ntekwasa ìhè pink anụ ahụ, ha biconvex na oval. On otu akụkụ e nwere ha osise "SOLVAY", na ndị ọzọ - "5044". On mbadamba "Teveten 600" na otu akụkụ kanyere na "SOLVAY", na ndị ọzọ - "5046".

The ọgwụ nwere a nhọrọ mmetụta angiotensin anabata, nke na-hụrụ na obi, adrenal cortex, ọbara arịa, akụrụ, akpụ a ike nkekọ na ha na a ngwa ngwa ụdi dissociation.

Teveten ndu akwadoro maka ọbara mgbali. Ọgwụ e ji ọnụ na, n'agbanyeghị nri oriri.

Teveten ntụziaka na ngwa na-atụ aro a onunu ogwu nke 600 mg ugboro kwa ụbọchị nke ụtụtụ.

N'ihi na ọrịa na hepatic impairment na ndị agadi ndị ọrịa nhọrọ nke na-amalite dose bụ chọrọ.

Na gbasara akụrụ odida kwa ụbọchị ikpenyeneke karịrị 600 mg.

Mmasị ka ọgwụ ọjọọ, "Teveten" ntụziaka na-enye ohere ya ruo ogologo oge iji.

Ikpe nke ovadozu kọwara na-adakarị omume ezughị. Mgbe ingestion nke ọgwụ na-emekarị nke ọma anabata.

Ọ na-ekwu irè mgbe a na-na kwa doses nke ruo 1.2 asatọ izu. N'isiokwu a gosiri na na nduzi nke ugboro nke oghom Jeremaya mere na dose.

The yikarịrị ihe ịrịba ama nke ihe ovadozu kwupụtara site ẹsụhọde ọbara mgbali. Gosiri maka ọnọdụ a symptomatic ọgwụ.

Mmasị ka ọgwụ ọjọọ, "Teveten" ntụziaka adịghị ekwe ka ya mbanye ndị antenatal oge na n'oge lactation. Na nchoputa nke afọ ime n'oge ọgwụgwọ na ọgwụ ga-ekpochapụ, ndụmọdụ banyere ekwe omume ekwesighi mmetụta. Mgbe ọ dị mkpa ka omume n'oge lactation ara ga-kwụsịtụrụ.

The ọgwụ nwere ike ime ka nwayọọ, adịteghị n'akụkụ Jeremaya mere. Dị ka na-aga n'ihu nnyocha, mpụta ìhè nke oghom mmetụta chọrọ ikpochapụ nke ọgwụ na naanị 4.1% nke ọrịa.

Oghom ngosipụta nke edinam pụtara "Teveten" ntụziaka ndị asthenia, dizziness, pruritus, isi ọwụwa, ọkụ ọkụ, angioedema, urticaria, ọzịza nke ihu, ụkwara.

The ọgwụ na-contraindicated na ụmụ (n'okpuru arọ iri na asatọ) afọ, na ikpe nke na hypersensitivity.

Na bilateral stenosis nke gbasara akụrụ akwara (akwara ma ọ bụ otu akụrụ), mbenata Bcc (ọbara olu) n'ihi afọ ọsịsa, vomiting ma ọ bụ iji elu doses nke diuretics, na oké obi ọdịda ọgwụ họpụtara na akpan akpan ịkpachara anya.

Ọ na-adịghị na-ewere a mere kagbuo Teveten-akwụsị akwụsị ọnụ ke ọbara mgbali. N'ọnọdụ dị otú ahụ, nsogbu na-Nọsi'ike na ụdi oriri.

Tupu oru nke ọgwụ na ọrịa na gbasara akụrụ insufficiency, nakwa dị ka mgbe nile ofụri ọgwụ na-nyochaa n'elu gbasara akụrụ ọrụ. Na ihe omume nke na-arịa ọrịa ga-nyochaa ọgwụgwọ.

Na oge nke ọgwụgwọ, ọrịa na-gwara iji ịkpachara anya na mmejuputa metụtara ngosipụta nke ọsọ nke psychomotor Jeremaya mere, mụbara anya. Nke a bụ n'ihi na likelihood nke dizziness ma ọ bụ adịghị ike.

Teveten kwere na-enweta ya na thiazide diuretics (hydrochlorothiazide gụnyere), hypolipidemic ọgwụ (gụnyere simvastatin, lovastatin, nicotinic acid, gemfibrozil, fenofibrate, paravastatinom), calcium ọwa igbochi elekọta mmadụ (na nifedipine nyere-ntọhapụ gụnyere) .